What does CervoMed Inc. do?
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the bloodbrain barrier and inhibits the enzyme p38a. Neflamapimod…
What is CervoMed Inc.'s P/E and P/B ratio?
CervoMed Inc. has a P/E ratio of -0.7 and a P/B ratio of 1.48.
What is CervoMed Inc.'s debt-to-equity ratio?
CervoMed Inc. has a debt-to-equity ratio of 0.00.
How much does CervoMed Inc. owe compared with what it owns?
CervoMed Inc. owes $0.12 for every $1 it owns (balance sheet Jun 2026), which is low.
What is CervoMed Inc.'s Positivity rank?
CervoMed Inc. is ranked #1,116 of 6,774 companies globally and #221 of 4,000 in United States on PositoAI, with a Positivity Score of 23,199.
Does CervoMed Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for CervoMed Inc..
Where can I read the latest news about CervoMed Inc.?
Recent headlines about CervoMed Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does CervoMed Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of CervoMed Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.